• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    PTC Therapeutics, Inc. (PTCT)

    -NasdaqGS
    70.48 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Prev Close:70.48
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:99.90
    Beta:-2.138
    Next Earnings Date: 4-May-15PTCT Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:14.51 - 78.72
    Volume:0
    Avg Vol (3m):654,524
    Market Cap:2.37B
    P/E (ttm):N/A
    EPS (ttm):-2.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PTCT 0.00%2.37B
    SRPT 0.00%554.97M
    VRTX 0.00%32.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):91.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-5.22
    Quarterly EPS Est (Mar-15) :-1.20
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.44

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback